How dihydropyridines modulate L-type voltage-gated Ca 2+ channels is not known. Dihydropyridines bind cooperatively with Ca 2+ binding to the selectivity filter, suggesting that they alter channel activity by promoting structural rearrangements in the pore. We used radioligand binding and patchclamp electrophysiology to demonstrate that calcicludine, a toxin from the venom of the green mamba snake, binds in the outer vestibule of the pore and, like Ca 2+ , is a positive modulator of dihydropyridine binding. Data were fit using an allosteric scheme where dissociation constants for dihydropyridine and calcicludine binding, K DHP and K CaC , are linked via the coupling factor, α. Nine acidic amino acids located within the S5-Pore-helix segment of repeat III were sequentially changed to alanine in groups of three resulting in the mutant channels, Mut-A, Mut-B and Mut-C. Mut-A, whose substitutions are proximal to IIIS5, exhibits a 4.5-fold reduction in dihydropyridine binding and is insensitive to calcicludine binding. Block of Mut-A currents by calcicludine is indistinguishable from wild-type, indicating that K CaC is unchanged and that the coupling between dihydropyridine and calcicludine binding (i.e., α) is disrupted. Mut-B and Mut-C possess K DHP values that resemble wild-type. Mut-C, the most C-terminal of the mutant channels, is insensitive to calcicludine binding and block. K CaC values for the Mut-C single mutants, E1122A, D1127A and D1129A, increase from 0.3 (Wild-type) to 1.14, 2.00 and 20.5 μM, respectively. Together, these findings suggest that dihydropyridine antagonist and calcicludine binding to L-type Ca 2+ channels promote similar structural changes in the pore that stabilize the channel in a nonconducting, blocked state.The flow of Ca 2+ ions through voltage-gated Ca 2+ channels drives a variety of cellular processes including excitation-contraction coupling, neurotransmitter release and gene expression. Voltage activated Ca 2+ channels are heteromultimeric complexes consisting of α 1 , β, α 2 /δ and sometimes γ subunits. The pore-forming α 1 subunit contains all of the structural determinants required for voltage-dependent gating, drug binding and ion permeation. The membrane topology of the α 1 subunit consists of four homologous repeats (I, II, III, IV), each consisting of six transmembrane segments (S1-S6). Each of the four S5/S6 connecting segments contains a highly conserved negatively charged glutamate residue that together form a binding site for Ca 2+ ions called the selectivity filter. The selectivity filter is the narrowest region in the pore and is the site that enables the channel to conduct Ca 2+ ions under physiological conditions where Na + is in excess (1). † This work was supported by research grants from the American Heart Association (0230298N) and the National Institutes of Health (RO1 HL074143) to B.Z.P. Important clues regarding the molecular basis for DHP action came from the finding that DHP binding to a site that lies outside the permeation pathway is cooperative w...